Posted on January 12, 2018 by Sitemaster
A small, Norwegian, Phase II clinical trial has explored the potential diagnostic value of [18F]fluciclovine PET/MRI scans of the pelvic lymph nodes in staging for patients with high-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Axumin, detection, lymph node, positive, risk, scan | 1 Comment »
Posted on March 18, 2015 by Sitemaster
The advent of imaging tests like the [11C]choline PET/CT scan and others have made it possible to identify, relatively early, the presence of one or more foci of recurrent prostate cancer after first-line therapy, and often these recurrent foci can be found in patients’ pelvic lymph nodes. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: choline, lymph node, PET/CT, positive, recurrent, salvage, Treatment | 10 Comments »
Posted on May 28, 2013 by Sitemaster
With the introduction of robot-assisted laparoscopic radical prostatectomy (RALP) there came suggestions from some surgeons that this technique made pelvic lymph node dissection (PLND) more difficult. However, a new review by a respected international group of authors clearly disagrees with this suggestion. … READ MORE …
Filed under: Management, Treatment | Tagged: dissection, laparoscopic, lymph node, pelvic, PLND, prostatectomy, RALP, robot-assisted, surgery | 5 Comments »
Posted on September 15, 2012 by Sitemaster
One of the hardest things to be able to do, currently, in a man with progressive prostate cancer after first- or second-line therapy, is to determine his risk for lymph node-positive prostate cancer or LNPPC (i.e., one of the earliest and more common components of metastatic prostate cancer). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: accuracy, identification, imaging, lymph node, positive, test | 5 Comments »
Posted on March 24, 2010 by Sitemaster
For several years a company initially called Advanced Magnetics (and later known as AMAG Pharma), with its partners, spent a good deal of money developing and seeking approval of a product called ferumoxtran-10. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Combidex, ferumoxtran-10, imaging, lymph node, metastasis, MRI | 36 Comments »
Posted on June 30, 2009 by Sitemaster
In todayas news reports we deal with items about:
- Celecoxib therapy prior to radical prostatectomy for cT1-2 disease
- Sentinel lymph node dissection (again)
- Surgical decompression and spinal reconstruction in man with spinal metastasis … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cedlecoxib, Celebrax, decompression, dissection, lymph node, sentinel, spinal metastases, surgery | Leave a comment »
Posted on June 26, 2009 by Sitemaster
A technique known as sentinel lymph node dissection (SLND) has replaced extended lymphadenectomy for nodal staging in several types of solid tumor cancers. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: dissection, lymph node, sentinel | Leave a comment »
Posted on June 17, 2009 by Sitemaster
One of the major issues in the management of prostate cancer is the identification of early physical (as opposed to biochemical) evidence of metastatic disease. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk | Tagged: Combidex, ferumoxtran-10, imaging, lymph node, metastasis | 2 Comments »